EP07.05. The Efficacy of Neoadjuvant Chemoimmunotherapy versus Neoadjuvant Chemotherapy in Resectable NSCLC, a Comparison Research from Real World - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Xinying Xue
Meta Tag
Speaker Xinying Xue
Topic Early-Stage NSCLC: Pushing the Boundaries
neoadjuvant chemoimmunotherapy
neoadjuvant chemotherapy
non-small cell lung cancer
objective response rates
major pathological response rates
pathological complete response rates
recurrence-free survival
overall survival rates
major pathological response status
Powered By